JACIE completed the first-ever inspection under the third edition Immune Effector Cells (IEC) Standards at Guy’s and St Thomas’ NHS Foundation Trust, expanding certification pathways for centers beyond transplant. The milestone signals that additional clinical sites may gain capability to conduct immune effector cell therapies under standardized inspection expectations. For the cellular therapy ecosystem, expanded inspection coverage can reduce bottlenecks in site readiness and help align operations with increasingly formalized quality benchmarks. It can also support scaling of programs that rely on consistent manufacturing and collection practices. The development matters for developers and sponsors because site qualification often governs timelines for trial execution, especially in immunotherapy and engineered cell platforms.